Affiliations 

  • 1 Department of Cardiology, Cardiovascular Institute, The First Affiliated Hospital of Harbin Medical University, Harbin, China
  • 2 Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
  • 3 Department of Cardiology, Memorial Ankara Hospital, Ankara, Turkey
  • 4 Department of Internal Medicine, Xiamen Chang Gung Memorial Hospital, Xiamen, China
  • 5 Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
  • 6 Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • 7 Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
  • 8 Department of Cardiovascular Medicine, Sapporo Cardiovascular Clinic, Sapporo Heart Center, Sapporo, Japan
  • 9 Department of Cardiology, Oita Cardiovascular Hospital, Oita, Japan
  • 10 Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China
  • 11 Departments of Cardiology and Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China
  • 12 Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
  • 13 Department of Cardiology, Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 14 Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, China
  • 15 Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China
  • 16 Department of Cardiology, National Heart Centre Singapore, Singapore, Singapore
  • 17 Department of Cardiology, Japanese Red Cross Musashino Hospital, Musashino, Tokyo, Japan
  • 18 Cardiovascular Research Foundation, New York, New York, USA
  • 19 Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China
  • 20 Department of Cardiology and Vascular Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia
  • 21 Department of Cardiology, The People's Hospital of Liaoning Province, Shenyang, China
  • 22 Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, China
  • 23 Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
  • 24 Department of Cardiovascular Medicine, The Sixth Medical Center of Chinese PLA General Hospital, Beijing, China
  • 25 Department of Cardiology, China-Japan Friendship Hospital, Beijing, China
  • 26 Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
  • 27 Department of Cardiology, Apollo Hospital, Chennai, India
  • 28 Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, China
  • 29 Department of Cardiology, Tianjin Medical University General Hospital, Tianjin, China
  • 30 Division of Cardiology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
  • 31 Faculty of Medicine, University of Malaya, Kuala Lumper, Malaysia
  • 32 Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China
  • 33 Department of Cardiology, Shuangyashan Shuangkuang Hospital, Shuangyashan, Heilongjiang, China
  • 34 Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China
  • 35 Division of Cardiology, Qingdao Cardiovascular Hospital, Qingdao, China
  • 36 Jordan cardiac society& Department of Cardiology, The University of Jordan, Amman, Jordan
  • 37 Department of Interventional Radiology, National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of the Russian Federation, Moscow, Russian Federation
  • 38 Department of Interventional Cardiology, Central Clinical Hospital, Novosibirsk, Russian Federation
  • 39 Cardiology Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
  • 40 Department of Cardiology, Cardiovascular Institute, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: ly99ly@vip.163.com
JACC Asia, 2026 Nov;6(11):2573-2587.
PMID: 42980228 DOI: 10.1016/j.jacasi.2026.08.029

Abstract

Coronary calcified nodules are an uncommon but important substrate for acute coronary syndromes, stent underexpansion, and recurrent target lesion revascularization. This consensus integrates pathologic, imaging, prognostic, and interventional evidence to guide practical decision-making. Intravascular imaging is essential for diagnosis, mechanism definition, and procedural optimization. Optical coherence tomography provides superior assessment of cap disruption and thrombus, whereas intravascular ultrasound remains valuable when contrast exposure or lesion crossing limits optical coherence tomography. Treatment should be tailored to lesion crossability, calcium distribution, and the need for mechanical scaffolding. No calcium-modification device or drug-eluting stent vs drug-coated balloon strategy has demonstrated consistent superiority. The proposed type IIa/IIb framework is hypothesis-generating and requires prospective validation. Calcified nodule-related target lesion failure should be managed by correcting the dominant mechanical mechanism before antiproliferative therapy. These recommendations emphasize individualized, imaging-guided percutaneous coronary intervention and identify priorities for prospective comparative research.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.